Department of Dermatology

CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion (2018) Heger L, Balk S, Lühr J, Heidkamp GF, Lehmann C, Hatscher L, Purbojo A, et al. Journal article Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway (2018) Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, et al. Journal article Myocarditis in Patients Treated With Immune Checkpoint Inhibitors (2018) Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling L, Sullivan RJ, et al. Journal article MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt MV, Eigentler TK, Berking C, Schadendorf D, et al. Journal article Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral Centres (2018) Kreuter A, Mitrakos G, Hofmann SC, Lehmann P, Sticherling M, Krieg T, Lahner N, et al. Journal article Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study (2018) Kampylafka E, D'Oliveira I, Linz C, Lerchen V, Stemmler F, Simon D, Englbrecht M, et al. Journal article Hypertonicity primes malignant melanoma cells for apoptosis (2018) Calance DN, Steixner C, Gross S, Schuler-Thurner B, Knoll G, Ehrenschwender M Journal article Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders (2018) Kaehler KC, Eigentler TK, Gesierich A, Heinzerling L, Loquai C, Meier F, Meiss F, et al. Journal article Willingness to pay for a cure of low-risk melanoma patients in Germany (2018) Augustin M, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al. Journal article Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers? (2018) Sticherling M Journal article